Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies

Stem Cells Dev. 2020 May 15;29(10):625-626. doi: 10.1089/scd.2020.0064. Epub 2020 Apr 3.

Authors

Hal E Broxmeyer¹, Graham C Parker²

Affiliations

¹ Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
² Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Betacoronavirus / physiology*
COVID-19
Cell- and Tissue-Based Therapy / adverse effects
Cell- and Tissue-Based Therapy / standards*
Cell- and Tissue-Based Therapy / trends*
Coronavirus Infections / prevention & control
Coronavirus Infections / transmission*
Coronavirus Infections / virology
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / standards*
Humans
Mass Screening / standards
Mass Screening / trends
Pandemics / prevention & control
Pneumonia, Viral / prevention & control
Pneumonia, Viral / transmission*
Pneumonia, Viral / virology
SARS-CoV-2
Tissue Donors / statistics & numerical data
Transplant Recipients

Grants and funding